| Detected | Trial | Change |
|---|---|---|
| 2026-08-12 | NCT06702631 Nitrous Oxide Neuroimaging |
Trial completed |
| 2026-08-12 | NCT06702631 Nitrous Oxide Neuroimaging |
Enrollment reduced: 60 -> 37 participants |
| 2026-08-12 | NCT06702631 Nitrous Oxide Neuroimaging |
date change Primary completion moved earlier: 2026-09-01 -> 2026-06-30 |
| 2026-08-12 | NCT06702631 Nitrous Oxide Neuroimaging |
date change Completion moved earlier: 2026-09-01 -> 2026-06-30 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Early Phase 1 | |||
| NCT07290205 | Remimazolam NeuroImaging | Anesthesia | Recruiting |
| NCT07294092 | Ketamine and Propofol NeuroImaging | Anesthesia | Recruiting |
| Not specified | |||
| NCT06825390 | AuriculoTherapy NeuroImaging | Low Back Pain | Recruiting |